Treatment of Chronic Delta Hepatitis With Lonafarnib.
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Lonafarnib (Primary)
- Indications Hepatitis D
- Focus Proof of concept; Therapeutic Use
- 17 Apr 2016 Pharmacokinetic, pharmacodynamics and viral kinetic results presented at The International Liver Congress™ 2016.
- 20 Jul 2015 Results published in an Eiger BioPharmaceuticals media
- 20 Jul 2015 According to an Eiger BioPharmaceuticals media release, data from this study were published in The Lancet Infectious Diseases.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History